Sundar Jagannath, MD¹, Ravi Vij, MD^2*, A. Keith Stewart, MBChB³, George Somlo, MD^4*, Andrzej Jakubowiak, MD, PhD⁵, Tony Reiman, MD⁶, Suzanne Trudel, MD^7*, Jessica Taylor, BA^8*, Diana Fuhrman, BSN^8*, Scott Cruickshank, MS^8*, Richard Schwartz, MD^8*, Lori Kunkel, MD^8*, David Siegel, MD, PhD⁹ and The Multiple Myeloma Research Consortium (MMRC)^10*

¹St. Vincent's Comp. Cancer Ctr., New York, NY
²Washington University School of Medicine, Saint Louis, MO
³Mayo Clinic, Scottsdale, AZ
⁴City of Hope, Duarte, CA
⁵Univ. of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁶Cross Cancer Institute, Edmonton, AB, Canada
⁷Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
⁸Clinical Operations, Proteolix, Inc., South San Francisco, CA
⁹Hackensack University Medical Center, Hackensack, NJ
¹⁰The Multiple Myeloma Research Consortium (MMRC), Norwalk, CT

Ravi Vij, MD^1*, Michael Wang, MD^2*, Robert Orlowski, MD, PhD^2*, A. Keith Stewart, MBChB³, Sundar Jagannath, MD⁴, Vishal Kukreti, MD, FRCPC⁵, Jessica Taylor, BA^6*, Diana Fuhrman, BSN^6*, Scott Cruickshank, MS^6*, Richard Schwartz, MD^6*, Lori Kunkel, MD^6*, David Siegel, MD, PhD⁷ and The Multiple Myeloma Research Consortium (MMRC)^8*

¹Washington University School of Medicine, Saint Louis, MO
²Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
³Mayo Clinic, Scottsdale, AZ
⁴St. Vincent's Comp. Cancer Ctr., New York, NY
⁵Princess Margaret Hospital, Toronto, ON, Canada
⁶Clinical Operations, Proteolix, Inc., South San Francisco, CA
⁷Hackensack University Medical Center, Hackensack, NJ
⁸The Multiple Myeloma Research Consortium (MMRC), Norwalk, CT

Martha Q. Lacy, MD¹, Suzanne R. Hayman^1*, Morie A. Gertz^1*, Jacob B. Allred^1*, Sumithra J. Mandrekar^1*, Angela Dispenzieri^1*, Stephen R. Zeldenrust^1*, Shaji Kumar^1*, Philip R. Greipp^1*, John A. Lust^1*, Stephen J Russell^1*, Francis Buadi^1*, Robert A. Kyle^1*, Peter Leif Bergsagel, MD², Rafael Fonseca, MD³, Vivek Roy, MD, FACP⁴, Joseph Mikhael, MD⁵, A. Keith Stewart, MBChB, MBA⁶ and S. Vincent Rajkumar^1*

¹Mayo Clinic, Rochester, MN
²Mayo Clinic, Scottsdale, AZ
³Mayo Clinic Scottsdale, Scottsdale, AZ
⁴Mayo Clinic, Jacksonville, FL
⁵Division of Hematology, Mayo Clinic, Scottsdale Campus, Scottsdale, AZ
⁶Research, Mayo Clinic Scottsdale, Scottsdale, AZ

Jean-François Rossi, MD, PhD^1*, Robert F. Manges, MD^2*, Heather J. Sutherland, MD, PhD³, Sundar Jagannath, MD⁴, Peter Voorhees, MD^5*, Pieter Sonneveld, MD⁶, Michel Delforge, MD, PhD^7*, Brigitte Pegourie, MD^8*, Adrian Alegre, MD^9*, Javier de la Rubia, MD^10*, David La Police, BS^11*, Rajesh Bandekar, PhD^11*, Hong Xie, MD^11* and Robert Z. Orlowski, MD, PhD^12*

¹CHU Montpellier, CIC BT509 and INSERM U475, Montpellier, France
²Investigative Clinical Research, L.L.C., Indianapolis, IN
³Vancouver General Hospital, Vancouver, BC, Canada
⁴St. Vincent's Comprehensive Cancer Center, New York, NY
⁵The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁶Erasmus Medical Center, Rotterdam, Netherlands
⁷University Hospital Gasthuisberg, Leuven, Belgium
⁸CHU de Grenoble, Hôpital Michallon, Grenoble, France
⁹Hospital de La Princesa, Madrid, Spain
¹⁰Hospital La Fe de Valencia, Valencia, Spain
¹¹Centocor Research & Development, Malvern, PA
¹²The University of Texas, M. D. Anderson Cancer Center, Houston, TX

Antonio Palumbo, MD¹, Patrizia Falco, MD^1*, Grazia Sanpaolo, MD^2*, Antonietta Falcone, MD^2*, Vincenzo Ferderico, MD^3*, Letizia Canepa, MD^4*, Monica Crugnola, MD^5*, Luca Baldini, MD^6*, Alessandra Larocca, MD^1*, Valeria Magarotto, MD^1*, Maria Teresa Petrucci, MD^3* and Mario Boccadoro, MD^1*

¹Divisione di Ematologia dell'Università di Torino, A.O.U. San Giovanni Battista, Torino, Italy
²UO Ematologia e Trapianto di Cellule Staminali, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy
³Dipartimento di Bioteconologie e Ematologia, Policlinico Umberto I - Università La Sapienza, Roma, Italy
⁴Clinica Ematologica, Ospedale San Martino Università di Genova, Genova, Italy
⁵Cattedra e UO Ematologia e Trapianti Midollo, Università degli Studi di Parma, Parma, Italy
⁶Unità Operativa Ematologia 1, Dipartimento di Ematologia e Oncologia, Ospedale Maggiore IRCCS, Milano, Italy

Efstathios Kastritis^1*, Ashutosh D Wechalekar^2*, Meletios A. Dimopoulos¹, Giampaolo Merlini^3*, Philip N Hawkins^2*, Vittorio Perfetti^4*, Julian D Gillmore^2* and Giovanni Palladini^3*

¹Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
²National Amyloidosis Center, University College London Medical School, United Kingdom
³Center for Amyloidosis, Fondazione IRCCS Policlinico San Matteo and Department of Biochemistry, University of Pavia, Italy
⁴Center for Amyloidosis and Department of Internal Medicine , Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Paul Richardson, MD¹, Jeffrey Wolf, MD^2*, Andrzej Jakubowiak, MD, PhD³, Jeffrey Zonder, MD⁴, Sagar Lonial, MD⁵, David H Irwin, MD^6*, John Densmore, MD, PhD⁷, Amrita Krishnan, MD, FACP⁸, Noopur Raje, MD^9*, Michael H. Bar, MD¹⁰, Jeffrey P. Allerton, MD¹¹, Robert Schlossman^1*, Irene M. Ghobrial, M.D.¹, Nikhil C. Munshi, MD¹, Thomas Martin, MD², Jacob Laubach, MD^1*, Kathy Colson, RN^1*, Sarah Dean^1*, Deanna Tocco^1*, Elizabeth Steinfield, RN^2*, Tara Kendall, PA^3*, Kimberly O'Riley, RN^4*, Teru Hideshima, MD, PhD¹, Peter Sportelli^12*, Lesa Gardner, RN^12* and Kenneth C. Anderson, MD¹

¹Dana-Farber Cancer Institute, Boston, MA
²University of California, SF, San Francisco, CA
³Univ. of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁴Wayne State University, Karmanos Cancer Institute, Detroit, MI
⁵Hematology and Medical Oncology, Emory Univesity, Atlanta, GA
⁶Alta Bates Comprehensive Cancer Center, Berkeley, CA
⁷Health Sciences Center, University of Virginia, Charlottesville, VA
⁸City of Hope National Medical Center, Duarte, CA
⁹Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
¹⁰Bennett Cancer Ctr., Stamford, CT
¹¹Guthrie Clinic, Sayre, PA
¹²Keryx Biopharmaceuticals, Inc., New York, NY

Donna Weber¹, Ashraf Z. Badros², Sundar Jagannath³, David Siegel⁴, Victoria Richon^5*, Syed Rizvi⁵, Jose Garcia-Vargas^5*, David Reiser^5* and Kenneth C. Anderson^6*

¹Department of Lymphona and Myeloma M.D., Anderson Cancer Center, Houston, TX
²University of Maryland, Baltimore, MD
³St. Vincent's Comp. Cancer Ctr., New York, NY
⁴Hackensack University Medical Center, Hackensack, NJ
⁵Merck & Co Inc., Upper Gwynedd, PA
⁶Medical Oncology, Dana Farber Cancer Institute, Brookline, MA